000 01639 a2200469 4500
005 20250516191729.0
264 0 _c20151008
008 201510s 0 0 eng d
022 _a1473-1150
024 7 _a10.1038/tpj.2013.49
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPadhukasahasram, B
245 0 0 _aGene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups.
_h[electronic resource]
260 _bThe pharmacogenomics journal
_cAug 2014
300 _a365-71 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdrenergic beta-Agonists
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aBlack or African American
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aGenome-Wide Association Study
650 0 4 _aGuanine Nucleotide Exchange Factors
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPharmacogenetics
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aPopulation Groups
700 1 _aYang, J J
700 1 _aLevin, A M
700 1 _aYang, M
700 1 _aBurchard, E G
700 1 _aKumar, R
700 1 _aKwok, P-Y
700 1 _aSeibold, M A
700 1 _aLanfear, D E
700 1 _aWilliams, L K
773 0 _tThe pharmacogenomics journal
_gvol. 14
_gno. 4
_gp. 365-71
856 4 0 _uhttps://doi.org/10.1038/tpj.2013.49
_zAvailable from publisher's website
999 _c23443842
_d23443842